2008
DOI: 10.1086/593334
|View full text |Cite
|
Sign up to set email alerts
|

Age‐ and Serotype‐Specific Pediatric Invasive Pneumococcal Disease: Insights from Systematic Surveillance in Santiago, Chile, 1994–2007

Abstract: Clinical syndromes of IPD and predominant serotypes vary with age.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
55
2
11

Year Published

2009
2009
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 70 publications
(75 citation statements)
references
References 33 publications
(42 reference statements)
5
55
2
11
Order By: Relevance
“…As in previous studies (21,22), most (94.6%) children hospitalized with acute respiratory disease were aged less than three years. Analysis of data from the prospective surveillance suggests that most (80.4%) suspected invasive pneumococcal diseases in Vietnamese children manifests initially as pneumonia.…”
Section: Characteristics Of Patientssupporting
confidence: 73%
“…As in previous studies (21,22), most (94.6%) children hospitalized with acute respiratory disease were aged less than three years. Analysis of data from the prospective surveillance suggests that most (80.4%) suspected invasive pneumococcal diseases in Vietnamese children manifests initially as pneumonia.…”
Section: Characteristics Of Patientssupporting
confidence: 73%
“…4,7 Serotype 14 is the major IPD pathogen among Chilean children aged 6-35 months but serotype 5 predominates among infants 0-5 months of age and serotype 1 is the most frequent in children aged 36-59 months and 5-14 years. 4 Moreover, serotypes 5 and 1 are more invasive than other serotypes.…”
Section: Introductionmentioning
confidence: 99%
“…Lagos R. y cols., evaluaron la cobertura teórica otorgada por estas vacunas para Chile, en base a un estudio de vigilancia activa de ENI efectuado en la Región Metropolitana entre los años 2000 y 2007, en lactantes y niños hospitalizados con edad igual o menor a 59 meses. Estos autores comprobaron que 54,4% de los casos de ENI correspondían a serotipos cubiertos por la vacuna 7-valente, en tanto que 72,4% por la vacuna 10-valente y finalmente 82,5% por la 13-valente 7 .…”
Section: Discussionunclassified